Metoclopramide Accord (Metoclopramide Hydrochloride Anhydrous)

Metoclopramide works by antagonizing dopamine D2 receptors in the chemoreceptor trigger zone, which reduces the brain’s nausea signal. In the gastrointestinal tract, it promotes the release of acetylcholine, leading to coordinated smooth‑muscle contractions that speed gastric emptying and raise lower esophageal sphincter pressure, thereby reducing reflux.

The appropriate dose of Metoclopramide Accord is determined by the prescribing healthcare professional based on the patient’s condition, age, renal function, and response to therapy. Dosage regimens vary, and the prescriber will tailor the amount and frequency to achieve the desired therapeutic effect while minimizing risk.

Safety data for metoclopramide in pregnancy and lactation are limited, and the drug should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the risks and alternatives with their healthcare provider before starting therapy.

To place an order, visit the product page on gnhindia.com and submit an enquiry with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Metoclopramide differs from many antiemetics such as 5‑HT3 antagonists by targeting dopamine D2 receptors and also offering pro‑kinetic activity that enhances gastric motility. This dual action makes it useful for conditions where delayed gastric emptying contributes to symptoms, whereas some alternatives focus solely on nausea pathways without affecting motility.

Metoclopramide Accord should be stored at room temperature, below 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture, excessive heat and direct sunlight. Do not store in a refrigerator or freezer unless the label specifically indicates otherwise.

Metoclopramide Accord is taken orally, usually with a glass of water. The tablet should be swallowed whole and not chewed or crushed unless directed by a healthcare professional. Dosing times and frequency are set by the prescriber, who may advise taking the medication before meals to maximize its pro‑kinetic effect.

The most serious risks include the development of tardive dyskinesia, a potentially irreversible movement disorder, and neuroleptic malignant syndrome, a life‑threatening condition characterized by high fever, muscle rigidity and autonomic instability. Patients should be monitored for early signs of these reactions, especially with prolonged use or high doses.

Metoclopramide Accord should be avoided in individuals with known hypersensitivity to metoclopramide or any component of the formulation, in patients with pheochromocytoma, and in those who have experienced severe extrapyramidal reactions to dopamine antagonists. Caution is also advised for patients with gastrointestinal obstruction, perforation, or hemorrhage.